Shifting the Paradigm to Pragmatic Evidence Generation
Integrated evidence generation (IEG) is a framework for generating evidence to support regulatory decision-making in healthcare, automate real-world data collection and grow evergreening data networks that fuel a variety of needs.
› READ THE BLOGPOSTERS
Addressing Gaps in Real-World Data Sources through Automated Extraction of Psychiatric Comorbidities and Medication Side Effects from Clinical Notes
MAY 9, 2024
At ISPOR Annual 2024, Jessica Probst, MPH presented in the AI in HEOR poster tour on Addressing Gaps in Real-World Data Sources through Automated Extraction of Psychiatric Comorbidities and Medication Side Effects from Clinical Notes. This poster was also a Top 5% Finalist for the ISPOR 2024 Research Presentation Awards. View the full poster >>
Real-World Characterization and Management of Alopecia Areata Patients in the U.S.
MAY 16, 2023
View our poster on Real-World Characterization and Management of Alopecia Areata Patients in the U.S. Click to view!
EVENTS
2025 SCOPE
JAN 2, 2025
SCOPE When: February 3-6, 2025 Where: Orlando, FL Booth # 328 OM1 will be at 2025 SCOPE in Orlando! Our clinical expertise and integrated evidence approach bring together real-world data, AI, and automated, regulatory-enabled platforms to help researchers fill in gaps along the patient journey from bench to bedside. Panel Title: Being Pragmatic About Pragmatic[…]
EBOOKS
2024 Data Insights
DEC 18, 2024
In 2024, AI revolutionized drug development in the broader pharmaceutical landscape. Companies increasingly integrated AI to accelerate research, optimize clinical trials, and personalize patient care. This trend underscores the growing importance of AI-driven solutions in enhancing patient treatment efficiencies and outcomes. OM1 is at the forefront of this transformation – our award-winning, patented AI-powered digital phenotyping[…]
Real-World Analytics: A Complimentary Suite of Analytic Reports
JUL 15, 2024
A complimentary suite of analytic reports for understanding the reasons behind medication discontinuation, patient outcomes, and prescribing behaviors. Introduction to Real-World Analytics Reasons for Discontinuation Report Comparative Outcomes Report Prescriber Trends Report Meet our Experts View the ebook >>
VIDEOS
PhenOM: AI Solutions
JUL 16, 2024
PhenOM® is an artificial intelligence (AI)-powered digital phenotyping platform trained using OM1’s repository of linked EMR, claims and other data covering more than 300 million patients. The richness of the source data lets these phenotypes capture many complex facets of the target patients’ journeys. View the video on YouTube >>
OM1 Aspen: Integrated Evidence Generation
JUL 16, 2024
OM1 Aspen leverages our proprietary data sourcing, processing and enrichment technologies, including electronic medical records harmonization, image management, advanced medical text processing and linkage, to deliver a more efficient, cost-effective and scalable approach to research. Tap into our networks or build new ones for automated evidence generation. Harness scientifically robust data from large and diverse[…]
NEWS & ARTICLES
Nalu PNS System Significantly Reduces Healthcare-Related Costs in Chronic Pain Patients
JAN 9, 2025
January 08, 2025 11:00 AM Eastern Standard Time CARLSBAD, Calif.–(BUSINESS WIRE)–Nalu Medical, Inc. (“Nalu”), a leader in peripheral nerve stimulation, announced the publication of a study in Pain Management journal showing that the use of Nalu PNS therapy in chronic pain patients is associated with lower healthcare resource utilization (HCRU) and a significant reduction in associated costs.,[…]
Revolutionizing Healthcare with AI: Insights from Dr. Joseph Zabinski
DEC 9, 2024
December 4, 2024 CARE to Lead® with Cynthia Corsetti Listen to the full podcast >> Cynthia Corsetti is joined on the Care to Lead podcast by Dr. Joseph Zabinski, Vice President and Head of Commercial Strategy and AI at OM1. With a PhD in Health Analytics and a Master’s in Engineering Management, Dr. Zabinski discusses[…]
WHITE PAPERS
From Big Data to Measurable Outcomes: OBC
JUL 6, 2017
A heightened focus on value is driving efforts across health care to improve outcomes and reduce costs. For pharmaceutical companies, this focus translates into a shift away from traditional payment models to more outcomes-based, risk sharing agreements. In many ways, these agreements present the opportunity to better align interests across health care’s stakeholders. However, they[…]
Improving Performance under Bundled Care
NOV 5, 2016
The field of medicine is changing rapidly due to two major disruptions – the application of artificial intelligence, such as machine and deep learning and the shift from fee-for-service to value-based payment models. These innovations, which are occurring simultaneously, are fundamentally altering how data are used and how care is provided. To survive in this[…]
WEBINARS
Transforming Cancer Detection: The Power of Real-World Evidence and AI in Multi-Cancer Early Detection (MCED) Studies
DEC 5, 2024
Register >> Friday, January 10th 2025 10:00 – 11:00 AM EST Webinar Synopsis Join us as we delve into the groundbreaking partnership between OM1 and Exact Sciences in the Falcon Registry Real-World Evidence (RWE) study. This ambitious initiative aims to enroll 25,000 patients across diverse backgrounds to evaluate the clinical impact of Multi-Cancer Early Detection[…]
Transform Your Patient Insights with AI-Enhanced Real-World Data
NOV 8, 2024
December 5, 2024 1:00 – 2:00pm ET Register >> In today’s complex healthcare landscape, going beyond traditional data is essential. Join our exclusive webinar to discover how scaling qualitative data from clinical notes, combined with AI, can reveal hidden patterns in patient journeys and treatment drivers, giving you a complete view of your therapy’s impact. Explore[…]